Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xtant Medical Holdings (XTNT) Enterprise Value (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Enterprise Value for 16 consecutive years, with -$10.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Enterprise Value fell 50.17% to -$10.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$10.6 million, a 50.17% decrease, with the full-year FY2024 number at -$6.2 million, down 5.03% from a year prior.
  • Enterprise Value was -$10.6 million for Q3 2025 at Xtant Medical Holdings, down from -$7.0 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$4.4 million in Q2 2023 to a low of -$20.5 million in Q2 2021.
  • A 5-year average of -$11.5 million and a median of -$8.7 million in 2023 define the central range for Enterprise Value.
  • Peak YoY movement for Enterprise Value: tumbled 685.43% in 2021, then soared 73.6% in 2023.
  • Xtant Medical Holdings' Enterprise Value stood at -$18.4 million in 2021, then fell by 11.53% to -$20.5 million in 2022, then soared by 71.12% to -$5.9 million in 2023, then decreased by 5.03% to -$6.2 million in 2024, then crashed by 71.05% to -$10.6 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Enterprise Value are -$10.6 million (Q3 2025), -$7.0 million (Q2 2025), and -$5.4 million (Q1 2025).